US
AstraZeneca sues FDA over generic Seroquel
March 14, 2012Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics
AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …
Pharma critical of Obama budget
February 15, 2012Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform
President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …
Pfizer hatches mail order plan for Lipitor
November 23, 2011Sales and Marketing Lipitor, Pfizer, US, generics
Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …
Janssen reaches partial agreement over criminal investigation
August 10, 2011Sales and Marketing Janssen, Risperdal, US, US Justice Department, illegal
Janssen Pharmaceuticals has reached a partial agreement with the US government over a criminal investigation into the marketing of Risperdal. …
US debt deal could hit pharma
August 2, 2011Sales and Marketing Obama, PhRMA, US, healthcare reform
The deal to raise America’s debt ceiling could have long-term consequences for the US pharma industry. The tense stand-off between …
GlaxoSmithKline OTC sale puts two plants on the block
April 19, 2011Manufacturing and Production GSK, US, pharma manufacturing
GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …
Eisai confirms 20% cut in US workforce
March 8, 2011Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts
Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …
Merck repels jaw injury claim
February 15, 2011Sales and Marketing Fosamax, Merck, US, lawsuit
A New Jersey state court jury has found in favour of Merck & Co in the company’s ongoing legal battle …
US healthcare ‘extreme makeover’ predicted for 2011
December 31, 2010Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC
Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …
US prescription drug prices rise above inflation
August 27, 2010Sales and Marketing US, prices
A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …
US court bars stem cell funding
August 26, 2010Sales and Marketing Obama, Stem cells, US
A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …
Pfizer signs ground-breaking academic research deal
May 18, 2010Research and Development Pfizer, US, academia, clinical research
Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …
Bayer opens US ‘science hub’
May 18, 2010Research and Development Bayer, US, acdemia, clinical research
Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …
AstraZeneca dodges another Seroquel lawsuit
April 8, 2010Sales and Marketing AZ, Seroquel, US
AstraZeneca has defeated another US lawsuit seeking compensation for diabetes side-effects allegedly caused by its drug Seroquel. A US Federal …
Healthcare reform momentus for pharma too
April 1, 2010Obama, US, biosimilars, healthcare reform
Historic reforms of America’s healthcare system have now passed into law, representing its most radical overhaul ever. Nevertheless, the bill …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
